China Sky One Medical, Inc. Raises Guidance for 2008 Revenue and ... (our recent acquisitionsand the success o...)

China Sky One Medical, Inc. Raises Guidance for 2008 Revenue and Net Income

Date:9/25/2008

our recent acquisitions and the success of a large advertising campaign for our products that we launched in the second quarter are helping to drive our sales," said Mr. Yan-Qing Liu, Chairman, President, and CEO of China Sky One Medicine Inc. "We believe that we will see strong future growth as we continue our strategy of hiring direct territory managers and sales agents to strengthen our distribution channels, as well as increase our R&D to develop a wider range of new and exciting products."

About China Sky One Medical, Inc.

China Sky One Medical, Inc., a Nevada corporation, is a holding company. The Company engages in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company, Harbin First Bio- Engineering Company Limited, and Heilongjiang Tianlong Pharmaceutical, Inc., the Company manufactures and distributes over-the- counter pharmaceutical products, which make up its major revenue source. For more information, visit http://www.skyonemedical.com .

Safe Harbor Statement

Certain of the statements made in the press release constitute forward- looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the use of forward- looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology. Such statements typically involve risks and uncertainties and may include financial projections or information regarding our future plans, objectives or performance. Actual results could differ materially from the expectations reflected in such forward-looking statements as a result of a variety of factors, including the risks associated with the effect of changing economic conditi
'/>"/>

0

GOOD

Page: 1 2 3
Related biology technology :

1. China-Biotics, Inc. Announces Results of 2008 Annual General Meeting of Shareholders
2. tootoo.com: Chinas Farmers Welcome the New Trend of Organic Farming
3. China Sky One Medical, Inc. Passes First Phase Examination for (CE) Certification
4. China Pharma Holdings, Inc. Projects 3rd Quarter 2008 Revenue Growth to Exceed 40%
5. China Biologic Receives SFDA Approval for Clinical Trial of Human Coagulation Factor VIII
6. China Biopharma Effects 1 for 100 Reverse Stock Split
7. China Sky One Medical, Inc. Completes Acquisition of Peng Lai Jin Chuang Company
8. China Yingxia International, Inc. Appoints New Vice President of Finance
9. China-Biotics, Inc. Provides Update on Construction of New Manufacturing Facility
10. China Biologic Products to Present at the SIG Beijing Management Summit
11. China Biologics Production Facility Renews GMP Certification

Post Your Comments:

China Sky One Medical, Inc. Raises Guidance for 2008 Revenue and ...(our recent acquisitionsand the success o...)